Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis

Arthritis and Rheumatism

Volumn 44, Issue 8, 2001, Pages 1744-1753

  Cunnane, Gaye ^a   Fitzgerald, Oliver ^a   Hummel, Klaus M ^b   Youssef, Peter P ^c   Gay, Renate E ^a   Gay, Steffen ^b   Bresnihan, Barry ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CATHEPSIN B; CATHEPSIN L; CD3 ANTIGEN; CD68 ANTIGEN; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PROTEINASE;

ADULT; AGED; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SYNOVIUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CATHEPSIN B; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; HUMANS; IN SITU HYBRIDIZATION; LEUKOCYTE COUNT; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; RNA, MESSENGER; SYNOVIAL MEMBRANE; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 0034881924     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200108)44:8<1744::AID-ART309>3.0.CO;2-K     Document Type: Article

References (56)

1. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: Two cellular mechanisms explain joint destruction?
2. The pathogenesis and prevention of joint damage in rheumatoid arthritis: Advances from synovial biopsy and tissue analysis
3. Metalloproteinase inhibitors and the prevention of connective tissue breakdown
4. Collagenase at sites of cartilage erosion in the rheumatoid joint
5. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis
6. Expression of collagenase and potential transcriptional factors in the MRL/1 mouse arthropathy
7. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury
8. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis
9. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium
10. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium
11. Interleukin-1β-stimulated invasion of articular cartilage by rheumatoid synovial fibroblasts is inhibited by antibodies to specific integrin receptors and by collagenase inhibitors
12. Degradation of cartilage matrix components by the cysteine proteases, cathepsin B and L
13. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis
14. Further studies on the activation of procollagenase, the latent precursor of bone collagenase: Effects of lysosomal cathepsin B, plasmin and kallikrein and spontaneous activation
15. Enzyme immunoassay for cathepsins B and L in synovial fluids from patients with arthritis
16. Collagenase, cathepsin B and cathepsin L expression in the synovial membrane of patients with early inflammatory arthritis
17. Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/1 mice and patients with rheumatoid arthritis
18. Cysteine proteinase activity in the development of arthritis in an adjuvant model of the rat
19. Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis
20. Cysteine proteinase activity in arthritic rat knee joints and the effects of a selective systemic inhibitor, Z-phe-ala-CH2F
21. Immunolocalization of metalloproteinases in collagen autoimmune arthritis
22. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
23. New York clinical criteria for ankylosing spondylitis: A statistical evaluation
24. Classification of clinical subsets in psoriatic arthritis
25. Methodological issues in radiographic scoring methods in rheumatoid arthritis
26. Microscopic measurement of synovial membrane inflammation in rheumatoid arthritis: Proposals for the evaluation of tissue samples by quantitative analysis
27. Quantitative analysis of synovial inflammation: A comparison between automated and conventional microscopic measurements
28. How important are T cells in chronic rheumatoid synovitis?
29. Mononclear phagocytes and rheumatoid synovitis: Mastermind or workhorse in arthritis?
30. Quantitative analysis of cytokine gene expression in rheumatoid arthritis
31. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages
32. Comparative studies of collagenase and stromelysin-1 expression by rheumatoid synoviocytes in vitro
33. Cytokines and oncogenes in cellular interactions of rheumatoid arthritis
34. Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis
35. Histomorphological basis of articular cartilage destruction in rheumatoid arthritis
36. Immunohistological analysis of the synovial membrane: Search for predictors of the clinical course in rheumatoid arthritis
37. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis
38. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization
39. Secretion of metalloproteinases by stimulated capillary endothelial cells
40. Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1)
41. Participation of cathepsin B in processing of antigen presentation to MHC class II
42. Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells
43. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: Suppression of collagenase-1 expression
44. Effects of treatment with interleukin-1 receptor antagonist on the synovial membrane and joints of patients with rheumatoid arthritis
45. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis
46. Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor α and interleukin-1
47. The proteolytic activation of interleukin-1beta
48. Temporal pattern of cysteine endopeptidase (cathepsin B) expression in cartilage and synovium from rabbit knees with experimental osteoarthritis: Gene expression in chondrocytes in response to interleukin-1 and matrix depletion
49. Arthritis of the finger joints: A comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging
50. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films
51. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?
52. How to read radiographs according to the Sharp/van der Heijde method
53. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of Genant and Larsen scores
54. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
55. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: A controlled magnetic resonance imaging study